跳至主要内容
临床试验/NCT04673032
NCT04673032已完成不适用

Radiofrequency (RF) Ablation Prospective Outcomes Study

Boston Scientific Corporation27 个研究点 分布在 4 个国家目标入组 298 人开始时间: 2020年12月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
298
试验地点
27
主要终点
Patient Global Impression of Change (PGIC)

研究概览

简要总结

The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems in the treatment of patients diagnosed with pain

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
0 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Study candidate is scheduled to be treated with a commercially approved Boston Scientific RF system for pain per local Directions for Use (DFU)
  • Signed a valid, IRB/EC/REB-approved informed consent form

排除标准

  • Meets any contraindications per locally applicable Directions for Use (DFU)
  • Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments

研究组 & 干预措施

Boston Scientific Radiofrequency Ablation Systems

Subjects with pain treated with a commercially approved Boston Scientific RF system

干预措施: Radiofrequency Ablation (Device)

结局指标

主要结局

Patient Global Impression of Change (PGIC)

时间窗: 12-months post-procedure

Using the Patient Global Impression of Change (PGIC) Scale, subjects will rate themselves as: very much improved; much improved; minimally improved; no change; minimally worse; much worse; or very much worse compared with Baseline

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (27)

Loading locations...

相似试验